Works matching IS 03407004 AND DT 2002 AND VI 51 AND IP 1

Results: 8

Vaccination with autologous tumour antigen-pulsed dendritic cells in advanced gynaecological malignancies: clinical and immunological evaluation of a phase I trial.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 45, doi. 10.1007/s00262-001-0255-1

By:

Hernando, Juan José;
Park, Tjoung-Won;
Kübler, Kirsten;
Offergeld, Ruth;
Schlebusch, Harald;
Bauknecht, Thomas

Publication type:

Article

Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 58, doi. 10.1007/s00262-001-0252-4

By:

Rees, Robert C.;
Pawelec, Graham;
Müller, Ludmila;
Robins, Adrian

Publication type:

Article

Binding to CD20 by Anti-B1 Antibody or F(ab')<sub>2</sub> is sufficient for induction of apoptosis in B-cell lines.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 15, doi. 10.1007/s00262-001-0247-1

By:

Cardarelli, Pina M.;
Quinn, Maire;
Buckman, Dana;
Yu Fang;
Colcher, David;
King, David J.;
Bebbington, Christopher;
Yarranton, Geoffrey

Publication type:

Article

The presence of interleukin-2 receptor alpha in the serum of colorectal cancer patients is unlikely to result only from T cell up-regulation.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 53, doi. 10.1007/s00262-001-0250-6

By:

Huang, Andy;
Quinn, Helen;
Glover, Clare;
Henderson, Don C.;
Allen-Mersh, Timothy G.

Publication type:

Article

A mutated superantigen SEA D227A fusion diabody specific to MUC1 and CD3 in targeted cancer immunotherapy for bile duct carcinoma.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 33, doi. 10.1007/s00262-001-0245-3

By:

Takemura, Shin-ichi;
Kudo, Toshio;
Asano, Ryutaro;
Suzuki, Masanori;
Tsumoto, Kouhei;
Sakurai, Naoki;
Katayose, Yu;
Kodama, Hideaki;
Yoshida, Hiroshi;
Ebara, Shinji;
Saeki, Hisaaki;
Imai, Kohzoh;
Matsuno, Seiki;
Kumagai, Izumi

Publication type:

Article

Generation of activated and antigen-specific T cells with cytotoxic activity after co-culture with dendritic cells.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 25, doi. 10.1007/s00262-001-0251-5

By:

Märten, Angela;
Greten, Tim;
Ziske, Carsten;
Renoth, Sabine;
Schöttker, Björn;
Buttgereit, Peter;
Schakowski, Frank;
von Rücker, Alexander;
Sauerbruch, Tilman;
Schmidt-Wolf, Ingo G. H.

Publication type:

Article

Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 9, doi. 10.1007/s00262-001-0249-z

By:

Maio, Michele;
Fonsatti, Ester;
Lamaj, Elda;
Altomonte, Maresa;
Cattarossi, Ilaria;
Santantonio, Cristina;
Melani, Cecilia;
Belli, Filiberto;
Arienti, Flavio;
Colombo, Mario P.;
Parmiani, Giorgio

Publication type:

Article

Killing activity of human umbilical cord blood-derived TCRValpha24<sup>+</sup> NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.

Published in:

Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 1, doi. 10.1007/s00262-001-0246-2

By:

Hagihara, Masao;
Gansuvd, Balgansuren;
Ueda, Yoko;
Tsuchiya, Takahide;
Masui, Aya;
Tazume, Kei;
Inoue, Hiroyasu;
Kato, Shunichi;
Hotta, Tomomitsu

Publication type:

Article